IMA
ImageneBio, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$64.46M
P/E Ratio
—
EPS
$-9.52
Beta
—
52W High
$18.00
52W Low
$3.94
50-Day MA
$5.74
200-Day MA
$8.26
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About ImageneBio, Inc.
ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | 800,000 |
| Gross Profit (TTM) | 800,000 |
| EBITDA | $-48.05M |
| Operating Margin | -6056.00% |
| Return on Equity | -68.90% |
| Return on Assets | -35.90% |
| Revenue/Share (TTM) | $0.15 |
| Book Value | $11.91 |
| Price-to-Book | 0.48 |
| Price-to-Sales (TTM) | 80.58 |
| EV/Revenue | 30.13 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $11.28M |
| Float | $6.26M |
| % Insiders | 14.96% |
| % Institutions | 50.32% |
Historical Volatility
HV 10-Day
50.06%
HV 20-Day
90.01%
HV 30-Day
83.92%
HV 60-Day
68.74%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($16.00 target)
2
Buy1
SellMore HEALTHCARE Stocks
Data last updated: 5/5/2026